Pyxis Oncology (PYXS) Equity Ratio: 2024-2025
Historic Equity Ratio for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to 0.65.
- Pyxis Oncology's Equity Ratio fell 17.23% to 0.65 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.65, marking a year-over-year decrease of 17.23%. This contributed to the annual value of 0.77 for FY2024, which is N/A change from last year.
- As of Q3 2025, Pyxis Oncology's Equity Ratio stood at 0.65, which was down 8.44% from 0.71 recorded in Q2 2025.
- In the past 5 years, Pyxis Oncology's Equity Ratio ranged from a high of 0.84 in Q1 2024 and a low of 0.65 during Q3 2025.
- Over the past 2 years, Pyxis Oncology's median Equity Ratio value was 0.77 (recorded in 2024), while the average stood at 0.76.
- Data for Pyxis Oncology's Equity Ratio shows a maximum YoY declined of 17.23% (in 2025) over the last 5 years.
- Pyxis Oncology's Equity Ratio (Quarterly) stood at 0.77 in 2024, then decreased by 17.23% to 0.65 in 2025.
- Its Equity Ratio was 0.65 in Q3 2025, compared to 0.71 in Q2 2025 and 0.76 in Q1 2025.